Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 10.73% | 61.50 | 0.0% | $1907.60m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.98% | 612.81 | 2.5% | $1175.40m | |
| GILD | Gilead Sciences, Inc. | 3.33% | 77.83 | 1.0% | $1168.63m | |
| AMGN | Amgen, Inc. | 2.49% | 229.70 | 1.3% | $672.54m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.81% | 287.96 | 1.9% | $606.67m | |
| NVAX | Novavax, Inc. | 2.68% | 46.04 | 102.0% | $590.02m | |
| BIIB | Biogen, Inc. | 2.19% | 307.09 | 1.6% | $417.42m | |
| ILMN | Illumina, Inc. | -2.67% | 363.05 | 3.5% | $387.48m | |
| SRNE | Sorrento Therapeutics, Inc. | 2.02% | 5.05 | 1.8% | $306.68m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 4.79% | 119.90 | 2.0% | $292.13m | |
| SGEN | Seattle Genetics, Inc. | 3.74% | 157.21 | 6.1% | $269.08m | |
| A | Agilent Technologies, Inc. | 1.67% | 88.14 | 1.6% | $202.48m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.90% | 106.55 | 4.3% | $186.35m | |
| CODX | Co-Diagnostics, Inc. | 3.03% | 18.00 | 0.0% | $173.36m | |
| INCY | Incyte Corp. | 1.35% | 101.91 | 2.5% | $166.15m |
Company Profile
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.